Moderna’s mNEXSPIKE Webinar | June 16-17, 2026

Moderna is hosting a webinar for health professionals on updates on its mNEXSPIKE (COVID-19, mRNA) on Tuesday, June 16, 2026, from 3:00 PM to 4:00 PM ET and Wednesday, June 17, 2026, from 12:00 PM to 1:00 PM ET.

In both sessions, presenters Dr. McKinney and Dr. Middleton will “review the evolving disease landscape, discuss the latest data on mNEXSPIKE (COVID-19 Vaccine, mRNA), and share clinical perspectives and best practices to support strong COVID-19 vaccine recommendations.” To view more details on Moderna’s upcoming webinar, click here.

Moderna’s mNexspike was approved by the FDA on May 31, 2025, for patients 65 years and older. Additionally, mNexspike is approved to be administered to patients 12 years and older with a high-risk condition. Asthma, cancer, diabetes, heart conditions, HIV, mental health conditions, obesity and many other diagnoses fall under the CDC’s list of high-risk conditions. To see the CDC’s complete list of high-risk conditions, please go here.